Clinical Trial Update: Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of Leucettinib-21 is enrolling healthy volunteers and individuals with Down syndrome and Alzheimer's disease. The trial is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Down Syndrome

Drugs mentioned

• Leucettinib-21 (Leucettinib-21)

Snippet

Sponsor: Perha Pharmaceuticals | Conditions: Healthy Volunteers, Down Syndrome | Phase 1 | Status: RECRUITING